When HAART is not enough.
Gilden
D
D
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D018791:CD4 Lymphocyte Count / Q000187:drug effects*; D018925:Chemokines / Q000502:physiology / Q000627:therapeutic use*; D016207:Cytokines / Q000502:physiology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006678:HIV / Q000187:drug effects* / Q000276:immunology; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects* / Q000235:genetics* / Q000276:immunology; D016753:Interleukin-10 / Q000627:therapeutic use*; D008297:Male; D010215:Papio; D010349:Patient Compliance; D018121:Receptors, Cytokine / Q000502:physiology*; D015728:Receptors, HIV / Q000502:physiology; D013950:Thymus Gland / Q000166:cytology; D017211:Treatment Failure; D019562:Viral Load; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D018925:Chemokines; D016207:Cytokines; D017320:HIV Protease Inhibitors; D018121:Receptors, Cytokine; D015728:Receptors, HIV; D016753:Interleukin-10